Cardiology
ESC Scientific Statement | Sex differences in arterial hypertension.
26 Sep, 2022 | 12:10h | UTC
Commentary on Twitter
Terrific work on this important statement on #sexdifferences in #hypertension @EvaGerdts @AnastasiaSMihai @MaasAngela et al! 👏🏽https://t.co/jhTXP0NTqJ pic.twitter.com/VBkbKLyV5K
— Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 (@DrMarthaGulati) September 23, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
M-A | Association of gestational diabetes mellitus with cardiovascular and cerebrovascular diseases.
26 Sep, 2022 | 12:01h | UTCNews Release: Diabetes in pregnancy linked to risk of cardiovascular and cerebrovascular disease – BMJ Newsroom
Commentary on Twitter
Gestational diabetes mellitus is associated with increased risks of overall and type specific cardiovascular and cerebrovascular diseases that cannot be solely attributed to conventional cardiovascular risk factors or subsequent diabetes, finds new studyhttps://t.co/0fCIXKVK99
— The BMJ (@bmj_latest) September 22, 2022
Cohort Study | Association of high‐sensitivity Troponin T and I with mortality and cardiovascular outcomes in stable patients.
26 Sep, 2022 | 11:59h | UTCInvited Commentary: Troponin in Stable Patients Undergoing Coronary Angiography: Should It Be Routinely Assessed? – Journal of the American Heart Association
Clinical risk score to predict pathogenic genotypes in patients with dilated cardiomyopathy.
26 Sep, 2022 | 11:57h | UTC
Commentary on Twitter
Is it possible to predict which pts w/ dilated cardiomyopathy/left ventricular dysfunction will have an assoc. predisposition on genetic testing?
Via the Madrid Score, Drs. @LuisEscobarL, @dr_pavia, & colleagues work to answer this question in #JACC: https://t.co/WDn8jA29aY pic.twitter.com/u0T9FffOwi
— JACC Journals (@JACCJournals) September 13, 2022
RCT | Insulin Glargine vs. Glimepiride vs. Sitagliptin vs. Liraglutide resulted in similar microvascular outcomes and death rates in patients with Type 2 diabetes not controlled with metformin.
22 Sep, 2022 | 13:20h | UTCGlycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes – New England Journal of Medicine (link to abstract – $ for full-text)
Related Study: Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes – New England Journal of Medicine
News Release: Two popular diabetes drugs outperformed others in large clinical trial – National Institutes of Health
Secondary analysis of a RCT | Complete revascularization vs. culprit lesion–only PCI for angina-related quality of life in patients with STEMI.
22 Sep, 2022 | 13:17h | UTCComplete Revascularization vs Culprit Lesion–Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)
Related meta-analysis:
Study: Nonculprit-lesion PCI Timing in Patients With ST-Segment Elevation Myocardial Infarction
Studies in patients with cardiogenic shock:
One-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine
A quality improvement study showed that a clinic–based aspirin deimplementation intervention can reduce inappropriate aspirin prescribing and bleeding in patients receiving warfarin for anticoagulation.
22 Sep, 2022 | 13:14h | UTCNews Release: Stopping aspirin when on a blood thinner lowers risk of bleeding, study finds – Michigan Medicine
Commentary on Twitter
An anticoagulation clinic–based #aspirin deimplementation intervention was associated with improved guideline-concordant aspirin use and fewer bleeding complications. https://t.co/kxKFZOdhae #Research
— JAMA Network Open (@JAMANetworkOpen) September 19, 2022
Consensus Statement | Cardiac computed tomographic imaging in cardio-oncology.
22 Sep, 2022 | 13:07h | UTC
Commentary on Twitter
New SCCT Expert Consensus co-endorsed by @ICOSociety: #YesCCT in Cardio-Oncology
This document fills existing gaps about CCT in Cardio-Oncology w experts in cardio-oncology, CCT imaging and cancer medicine @journalCCT 👉https://t.co/lNaQ37sKoQ@onco_cardiology @CardiacCTGuy pic.twitter.com/hILbBimfmZ
— Heart_SCCT (@Heart_SCCT) September 19, 2022
M-A | Optimal pharmacologic treatment of heart failure with preserved and mildly reduced ejection fraction.
22 Sep, 2022 | 13:05h | UTCRelated M-A: SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials – The Lancet (link to abstract – $ for full-text)
RCT | Effect of clinical decision support with audit and feedback on prevention of acute kidney injury in patients undergoing coronary angiography.
22 Sep, 2022 | 13:04h | UTCEffect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary: Intervention Cuts Risk for AKI After Coronary Angiography – HealthDay
Commentary on Twitter
This multifaceted intervention led to a lower risk of acute kidney injury in patients undergoing coronary angiography, percutaneous coronary intervention, or both. #Research https://t.co/rKVBsRxHy7
— JAMA (@JAMA_current) September 7, 2022
RCT | Routine ultrasonography guidance for femoral vascular access for cardiac procedures improved first-pass success but did not reduce complications.
22 Sep, 2022 | 13:01h | UTCRoutine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial – JAMA Cardiology (free for a limited period)
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
22 Sep, 2022 | 13:00h | UTCAnti-interleukin-1 agents for pericarditis: a primer for cardiologists – European Heart Journal
Commentary on Twitter
Must read review: anti-interleukin-1 agents for pericarditis https://t.co/veLfNKpWHR #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/k50O8R0vbM
— European Society of Cardiology Journals (@ESC_Journals) September 21, 2021
Echocardiography in prone positioned critically ill patients: a wealth of information from a single view.
22 Sep, 2022 | 12:58h | UTC
Pulmonary artery denervation for pulmonary arterial hypertension: a sham-controlled randomized trial.
21 Sep, 2022 | 13:21h | UTCCommentaries:
Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test – TCTMD
Commentary on Twitter
#TCT2022 #JACCINT LBCT SimPub: PADN-CFDA trial included 128 pts w/ #cvPAH. At 6-month follow-up, PADN assoc. w/ a ⬆️ improvement in 6MWD, PVR, RV function, & ⬇️ NT-proBNP. Clinical worsening was ⬇️ & satisfactory clinical response was ⬆️ in the PADN group. https://t.co/3IVaUwCgOT pic.twitter.com/bylhcA4GrQ
— JACC Journals (@JACCJournals) September 18, 2022
ISHLT consensus statement | Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.
21 Sep, 2022 | 13:15h | UTC
Long-term follow-up of a RCT | Percutaneous coronary intervention vs. bypass surgery for multivessel coronary artery disease.
20 Sep, 2022 | 13:34h | UTCOriginal Study: Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease – New England Journal of Medicine
Long-term follow-up of a RCT | Outcomes after catheter-based renal artery denervation for resistant hypertension.
20 Sep, 2022 | 13:33h | UTCLong-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial – The Lancet (free registration required)
Commentary: SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss – TCTMD
Original Study: A Controlled Trial of Renal Denervation for Resistant Hypertension – New England Journal of Medicine
Network M-A | Associations between statins and adverse events in secondary prevention of cardiovascular disease.
20 Sep, 2022 | 13:30h | UTC
A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction.
20 Sep, 2022 | 13:16h | UTCA Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction – JAMA Cardiology (link to abstract – $ for full-text)
Commentary on Twitter
This cohort study found that a simple 6 variable clinical score may be used to guide use of PYP and increase recognition of cardiomyopathy (ATTR-CM) among patients with HFpEF in the community. https://t.co/2fzCZf97Mp #Research
— JAMA Cardiology (@JAMACardio) September 7, 2022
Evaluation of an ambulatory ECG analysis platform using deep neural networks in routine clinical practice.
20 Sep, 2022 | 13:14h | UTC
Commentary on Twitter
An AI-based Holter ECG analysis strategy saves time and performs similarly compared with a conventional approach @EloiMarijon #AHAJournals https://t.co/lK7h0po4xj
— JAHA (@JAHA_AHA) September 15, 2022
RCT | Cerebral embolic protection during transcatheter aortic-valve replacement did not significantly reduce the incidence of periprocedural stroke.
19 Sep, 2022 | 12:49h | UTCCerebral Embolic Protection during Transcatheter Aortic-Valve Replacement – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope – TCTMD
Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven — Large trial comes up short in proving a definitive benefit to debris filters – MedPage Today (free registration required)
News Release: Cerebral Embolic Protection During Transcatheter Aortic-Valve Replacement – Cedars-Sinai
Commentary on Twitter
In a randomized trial involving patients with aortic stenosis, the use of a cerebral protection device during TAVR did not decrease the risk of periprocedural stroke, but there were fewer disabling strokes. #TCT2022 https://t.co/wBgNlgmIty pic.twitter.com/EViLG19shX
— NEJM (@NEJM) September 17, 2022
Guideline Synopsis | AHA/ACC Guideline for the management of heart failure.
16 Sep, 2022 | 13:01h | UTCManagement of Heart Failure – JAMA (free for a limited period)
Original Article: #ACC22 – 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
AHA Scientific Statement | Management of patients at risk for and with left ventricular thrombus.
16 Sep, 2022 | 13:00h | UTC
Study | The specificity and positive predictive value of high-sensitivity cardiac troponin I for the diagnosis of myocardial infarction are reduced in older individuals.
16 Sep, 2022 | 12:57h | UTCInfluence of Age on the Diagnosis of Myocardial Infarction – Circulation
Consensus Statement | How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases.
16 Sep, 2022 | 12:56h | UTC